These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28388549)

  • 1. Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.
    Sun X; Zhang G; Nian J; Yu M; Chen S; Zhang Y; Yang G; Yang L; Cheng P; Yan C; Ma Y; Meng H; Wang X; Li JP
    Oncotarget; 2017 Jun; 8(26):43521-43535. PubMed ID: 28388549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
    Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
    Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of expression of heparanase to angiogenesis and prognosis of breast cancer].
    Liu ZZ; Zhang HW; Wei B; Cui SD
    Ai Zheng; 2004 Nov; 23(11):1342-5. PubMed ID: 15522187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins.
    Kong W; Zhang G; Wang Y; Zhang J; Ding T; Chen D; Pan Y; Yi R; Yin X; Wang X
    Technol Cancer Res Treat; 2024; 23():15330338241281285. PubMed ID: 39248214
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparanase and COX-2 expression as predictors of lymph node metastasis in large, high-grade breast tumors.
    Gawthorpe S; Brown JE; Arif M; Nightingale P; Nevill A; Carmichael AR
    Anticancer Res; 2014 Jun; 34(6):2797-800. PubMed ID: 24922641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PD-L1 and prognosis in breast cancer: a meta-analysis.
    Zhang M; Sun H; Zhao S; Wang Y; Pu H; Wang Y; Zhang Q
    Oncotarget; 2017 May; 8(19):31347-31354. PubMed ID: 28430626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
    Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
    BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 induction by heparanase in the progression of breast cancer.
    Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
    Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
    Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
    Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase augments insulin receptor signaling in breast carcinoma.
    Goldberg R; Sonnenblick A; Hermano E; Hamburger T; Meirovitz A; Peretz T; Elkin M
    Oncotarget; 2017 Mar; 8(12):19403-19412. PubMed ID: 28038446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
    Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
    Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of heparanase expression in metastatic melanoma.
    Vornicova O; Boyango I; Feld S; Naroditsky I; Kazarin O; Zohar Y; Tiram Y; Ilan N; Ben-Izhak O; Vlodavsky I; Bar-Sela G
    Oncotarget; 2016 Nov; 7(46):74678-74685. PubMed ID: 27732945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase expression correlates with malignant potential in human colon cancer.
    Nobuhisa T; Naomoto Y; Ohkawa T; Takaoka M; Ono R; Murata T; Gunduz M; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Tsujigiwa H; Nagatsuka H; Nakajima M; Tanaka N
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):229-37. PubMed ID: 15625607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis.
    Boyango I; Barash U; Fux L; Naroditsky I; Ilan N; Vlodavsky I
    Matrix Biol; 2018 Jan; 65():91-103. PubMed ID: 28916201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.
    Theodoro TR; de Matos LL; Sant Anna AV; Fonseca FL; Semedo P; Martins LC; Nader HB; Del Giglio A; da Silva Pinhal MA
    Neoplasia; 2007 Jun; 9(6):504-10. PubMed ID: 17603633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase protein and gene expression in bladder cancer.
    Gohji K; Okamoto M; Kitazawa S; Toyoshima M; Dong J; Katsuoka Y; Nakajima M
    J Urol; 2001 Oct; 166(4):1286-90. PubMed ID: 11547059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
    Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
    Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.